Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Yingsheng Bio Technology is a leading Chinese developer of mass spectrometry-based clinical diagnostic solutions. The company offers an integrated platform that includes high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) systems, automated sample processing, and specialized reagent kits. Their product portfolio primarily addresses newborn screening, vitamin quantification, and therapeutic drug monitoring. Yingsheng Bio has established strategic partnerships with global leaders like Thermo Fisher Scientific to advance the application of mass spectrometry in precision medicine. The company is recognized as a key player in the transition of mass spectrometry from research settings to routine clinical diagnostics in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Yingsheng Bio Technology.